Gene · 1491
Papers3,417
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,417
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Relationship between Elevated Homocysteine and Metabolic Syndrome in a Community-Dwelling Middle-Aged and Elderly Population in Taiwan. | Biomedicines | 2023 | 36830912 | PubTator, text mining | PubMed |
| The Complex Genetic and Epigenetic Regulation of the Nrf2 Pathways: A Review. | Antioxidants (Basel) | 2023 | 36829925 | PubTator, text mining | PubMed |
| S-Propargyl-Cysteine Ameliorates Peripheral Nerve Injury through Microvascular Reconstruction. | Antioxidants (Basel) | 2023 | 36829853 | PubTator, text mining | PubMed |
| Polysulfide Serves as a Hallmark of Desmoplastic Reaction to Differentially Diagnose Ductal Carcinoma In Situ and Invasive Breast Cancer by SERS Imaging. | Antioxidants (Basel) | 2023 | 36829799 | PubTator, text mining | PubMed |
| Reduced Renal CSE/CBS/H2S Contributes to the Progress of Lupus Nephritis. | Biology (Basel) | 2023 | 36829595 | PubTator, text mining | PubMed |
| Local delivery of gaseous signaling molecules for orthopedic disease therapy. | J Nanobiotechnology | 2023 | 36810201 | PubTator, text mining | PubMed |
| Inhibition of nitric oxide synthase or cystathionine gamma-lyase abolishes leptin-induced fever in male rats. | J Therm Biol | 2023 | 36796898 | PubTator, text mining | PubMed |
| A Pharmacological Review of Tanshinones, Naturally Occurring Monomers from Salvia miltiorrhiza for the Treatment of Cardiovascular Diseases. | Oxid Med Cell Longev | 2023 | 36793978 | PubTator, text mining | PubMed |
| Research progress and insights on the role of ferroptosis in wound healing. | Int Wound J | 2023 | 36788729 | PubTator, text mining | PubMed |
| Hydrogen sulfide as an anti-calcification stratagem in human aortic valve: Altered biogenesis and mitochondrial metabolism of H2S lead to H2S deficiency in calcific aortic valve disease. | Redox Biol | 2023 | 36780769 | PubTator, text mining | PubMed |
| H2S Sensors: Synthesis, Optical Properties, and Selected Biomedical Applications under Visible and NIR Light. | Molecules | 2023 | 36770961 | PubTator, text mining | PubMed |
| H2S- and Redox-State-Mediated PTP1B S-Sulfhydration in Insulin Signaling. | Int J Mol Sci | 2023 | 36769221 | PubTator, text mining | PubMed |
| Differential Roles of Cystathionine Gamma-Lyase and Mercaptopyruvate Sulfurtransferase in Hapten-Induced Colitis and Contact Dermatitis in Mice. | Int J Mol Sci | 2023 | 36768979 | PubTator, text mining | PubMed |
| Detectable Lipidomes and Metabolomes by Different Plasma Exosome Isolation Methods in Healthy Controls and Patients with Advanced Prostate and Lung Cancer. | Int J Mol Sci | 2023 | 36768152 | PubTator, text mining | PubMed |
| Cystathionine γ-lyase S-sulfhydrates SIRT1 to attenuate myocardial death in isoprenaline-induced heart failure. | Redox Rep | 2023 | 36757027 | PubTator, text mining | PubMed |
| Inhibition of endogenous hydrogen sulfide production suppresses the growth of nasopharyngeal carcinoma cells. | Mol Carcinog | 2023 | 36752346 | PubTator, text mining | PubMed |
| Planar carbon electrodes for real-time quantification of hydrogen sulfide release from cells. | Sens Diagn | 2023 | 36741248 | PubTator, text mining | PubMed |
| Interactions of reactive sulfur species with metalloproteins. | Redox Biol | 2023 | 36738685 | PubTator, text mining | PubMed |
| CBS-H2S axis preserves the intestinal barrier function by inhibiting COX-2 through sulfhydrating human antigen R in colitis. | J Adv Res | 2023 | 36725190 | PubTator, text mining | PubMed |
| Cystathionine gamma-lyase (Cth) induces efferocytosis in macrophages via ERK1/2 to modulate intestinal barrier repair. | Cell Commun Signal | 2023 | 36691021 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1491/papers?page=20